UBS Downgrades GE HealthCare Techs to Sell, Lowers Price Target to $66
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Graham Doyle has downgraded GE HealthCare Technologies (GEHC) from Neutral to Sell and reduced the price target from $86 to $66.
November 27, 2023 | 10:51 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
GE HealthCare Technologies downgraded by UBS from Neutral to Sell, with a significant reduction in price target from $86 to $66.
Analyst downgrades typically lead to a negative short-term reaction in the stock price as they suggest a bearish outlook. The substantial decrease in the price target further implies a lack of confidence in the company's short-term performance prospects.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100